Against Our Instincts: Decriminalization of Buprenorphine

References

1. 1.↵
   1. Ahmad F,
   2. Rossen L,
   3. Sutton P

   . Provisional drug overdose death counts. Published online 2021.
2. 2.↵
   1. Santo T,
   2. Clark B,
   3. Hickman M,
   4. et al

   . Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021;78:979–93.

   OpenUrl
3. 3.↵
   1. Huhn AS,
   2. Dunn KE

   . Why aren't physicians prescribing more buprenorphine? J Subst Abuse Treat 2017;78:1–7.

   OpenUrlPubMed
4. 4.↵
   1. Sevarino KA,
   2. Nielsen P,
   3. Kushner M,
   4. et al

   . Letter to Acting Secretary Norris Cochran and Acting Director Regina LaBelle. Published online February 18, 2021. http://www.aatod.org/wp-content/uploads/2021/02/data2000.letter.coalition.pdf.
5. 5.↵
   1. Lofwall MR,
   2. Walsh SL

   . A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World. J Addict Med 2014;8:315–26.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Walsh SL,
   2. Preston KL,
   3. Stitzer ML,
   4. Cone EJ,
   5. Bigelow GE

   . Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569–80.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   Tennessee Department of Health Office of Informatics & Analytics. 2020 Buprenorphine Report. Published online November 2020. https://www.tn.gov/content/dam/tn/health/documents/pdo/2020%20Buprenorphine%20Report_11.30.pdf.
8. 8.↵
   1. Paone D,
   2. Tuazon E,
   3. Stajic M,
   4. et al

   . Buprenorphine infrequently found in fatal overdose in New York City. Drug Alcohol Depend 2015;155:298–301.

   OpenUrl
9. 9.↵
   1. Chilcoat HD,
   2. Amick HR,
   3. Sherwood MR,
   4. Dunn KE

   . Buprenorphine in the United States: Motives for abuse, misuse, and diversion. J Subst Abuse Treat 2019;104:148–57.

   OpenUrl
10. 10.↵
    1. Evans EA,
    2. Yoo C,
    3. Huang D,
    4. Saxon AJ,
    5. Hser Y-I

    . Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder. J Subst Abuse Treat 2019;106:19–28.

    OpenUrl
11. 11.↵
    1. Fox AD,
    2. Chamberlain A,
    3. Sohler NL,
    4. Frost T,
    5. Cunningham CO

    . Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat 2015;48:112–6.

    OpenUrl
12. 12.↵
    1. Carlson RG,
    2. Daniulaityte R,
    3. Silverstein SM,
    4. Nahhas RW,
    5. Martins SS

    . Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose? Int J Drug Policy 2020;79:102722.

    OpenUrl
13. 13.↵
    1. Kenney SR,
    2. Anderson BJ,
    3. Bailey GL,
    4. Stein MD

    . Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management. J Subst Abuse Treat 2018;94:55–9.

    OpenUrl
14. 14.↵
    1. Piper BJ,
    2. Desrosiers CE,
    3. Fisher HC,
    4. McCall KL,
    5. Nichols SD

    . A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program. Pharmacotherapy 2017;37:791–8.

    OpenUrlCrossRef
15. 15.↵
    United States Department of Justice Civil Rights Division, United States Attorney's Office District of New Jersey. Investigation of the Cumberland County Jail (Bridgeton, New Jersey). Published online January 14, 2021. https://www.justice.gov/opa/press-release/file/1354646/download.
16. 16.↵
    1. Larochelle MR,
    2. Bernstein R,
    3. Bernson D,
    4. et al

    . Touchpoints – Opportunities to predict and prevent opioid overdose: A cohort study. Drug Alcohol Depend 2019;204:107537.

    OpenUrlPubMed
17. 17.↵
    1. Pozo BD,
    2. Krasner LS,
    3. George SF

    . Decriminalization of Diverted Buprenorphine in Burlington, Vermont and Philadelphia: An Intervention to Reduce Opioid Overdose Deaths. J Law Med Ethics 2020;48:373–5.

    OpenUrl